|
Menadione Injection
» Menadione Injection is a sterile solution of Menadione in oil. It contains not less than 90.0 percent and not more than 120.0 percent of the labeled amount of C11H8O2.
Packaging and storage
Preserve in single-dose or in multiple-dose containers, preferably of Type I glass.
Bacterial endotoxins
Other requirements
It meets the requirements under Injections
Assay
[noteAvoid exposing Menadione and its solutions to light throughout the Assay.]
Standard preparation
Transfer about 25 mg of USP Menadione RS, accurately weighed, to a 100-mL volumetric flask, dissolve in a mixture of equal volumes of alcohol and ether, dilute with the same mixture to volume, and mix. Keep the solution tightly closed in a dark, cool place, and use it within 7 days.
Assay preparation
Transfer an accurately measured volume of Injection, equivalent to about 25 mg of menadione, to a 100-mL volumetric flask, dilute with a mixture of equal volumes of ether and alcohol to volume, and mix.
Procedure
Transfer 1.0 mL each of the Standard preparation and the Assay preparation to separate 50-mL volumetric flasks, add to each 4 mL of alcohol, and mix. Then to each flask add 1.0 mL of a solution prepared by dissolving 50 mg of 2,4-dinitrophenylhydrazine in 20 mL of a mixture of 2 volumes of 3 N hydrochloric acid and 1 volume of water. Place the flasks in a bath maintained at 70
(0.1C / V)(AU / AS)
in which C is the concentration, in µg per mL, of USP Menadione RS in the Standard preparation, V is the volume, in mL, of Injection taken, and AU and AS are the absorbances of the solutions from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 2878
|